All Headlines >>
Animalcare has announced the launch of Thiafeline (Thiamazole 2.5mg and 5mg) for the management of hyperthyroidism in cats.
An estimated 12% of UK cats over the age of nine suffer from hyperthyroidism², which could equate to almost 350,000 cats³. In one study, 92% of cats diagnosed with hyperthyroidism were stable after four weeks treatment (on the twice daily 2.5mg dosing) with thiamazole¹
Thiafeline is presented as a blister pack, which Animalcare says offers the benefits of easy dispensing, improved stock control and no nurse exposure during dispensing for increased safety in practice. This format also allows pet owners to monitor the dosage and quantities easily, for an uninterrupted course of medication.
Animalcare says that whilst many of the clinical signs for hyperthyroidism are easily recognised, it understands that diagnosis is not always straightforward. For this reason, the company has produced support materials for Thiafeline users including diagnosis best practice charts for use within practice and a pet owner awareness package for use in waiting rooms.
Beverley Hammond, Product Manager for Thiafeline said: "While initial signs associated with hyerperthyroidism can appear quite mild it is important for pet owners to understand that if left untreated the condition can lead to serious secondary complications. It's easy for owners to assume that the signs they are seeing are simply related to old age so our campaign will aim to increase the amount of owners bringing their cats for senior pet checks and also ensure that vets are following the best practice procedures to reach a definitive diagnosis."
References
PS: Whilst you're here, take a moment to see our latest job opportunities for vet nurses.